Literature DB >> 22972503

Expression of the molecular chaperone αB-crystallin in infiltrating ductal breast carcinomas and the significance thereof: an immunohistochemical and proteomics-based strategy.

Maria Kabbage1, Mounir Trimeche, Hela Ben Nasr, Philippe Hammann, Lauriane Kuhn, Bechr Hamrita, Anouar Chaieb, Lotfi Chouchane, Karim Chahed.   

Abstract

This study aims to evaluate αB-crystallin expression in infiltrating ductal breast carcinomas (IDCAs), as well as, its prognostic significance. Using a two-dimensional electrophoresis matrix-assisted laser desorption/ionisation-time of flight mass spectrometry investigation coupled to an immunohistochemical approach, we have assessed the expression of αB-crystallin in IDCAs, as well as, in other types of breast tumors (invasive lobular carcinomas, medullary carcinomas, and in situ ductal carcinomas). Correlation between αB-crystallin expression and clinicopathological parameters of breast cancer has also been investigated. Proteomic analyses revealed an increased expression of αB-crystallin in IDCA tumors compared to adjacent nontumor tissues. Overexpression of this molecular chaperone was further confirmed in 51 tumor specimens. Statistical analyses revealed, however, no significant correlations between αB-crystallin expression and clinicopathological parameters of the disease (tumor stage, patient age, hormone receptors, SBR grade, and lymph node metastases). This study demonstrates the upregulation of αB-crystallin in IDCA tissues which may highlight its possible involvement in breast cancer development. Our findings do not, however, support the involvement of this molecular chaperone in the progression of this disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22972503     DOI: 10.1007/s13277-012-0490-4

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  47 in total

1.  Expression of fibrinogen E-fragment and fibrin E-fragment is inhibited in the human infiltrating ductal carcinoma of the breast: the two-dimensional electrophoresis and MALDI-TOF-mass spectrometry analyses.

Authors:  Karim Chahed; Maria Kabbage; Laurence Ehret-Sabatier; Christelle Lemaitre-Guillier; Sami Remadi; Johan Hoebeke; Lotfi Chouchane
Journal:  Int J Oncol       Date:  2005-11       Impact factor: 5.650

2.  Differential expression of alphaB-crystallin and Hsp27-1 in anaplastic thyroid carcinomas because of tumor-specific alphaB-crystallin gene (CRYAB) silencing.

Authors:  Ivelina Mineva; Wolfgang Gartner; Peter Hauser; Alexander Kainz; Michael Löffler; Gerhard Wolf; Rainer Oberbauer; Michael Weissel; Ludwig Wagner
Journal:  Cell Stress Chaperones       Date:  2005       Impact factor: 3.667

3.  ΑB-crystallin in clear cell renal cell carcinoma: tumor progression and prognostic significance.

Authors:  Pei-Yin Ho; Shih-Chieh Chueh; Shyh-Horng Chiou; Shuo-Meng Wang; Wei-Chou Lin; I-Liang Lee; Hsin-Yi Yang; Hsiang-Chi Peng; Ming-Kuen Lai
Journal:  Urol Oncol       Date:  2012-03-13       Impact factor: 3.498

Review 4.  Surface-exposed calreticulin in the interaction between dying cells and phagocytes.

Authors:  Isabelle Martins; Oliver Kepp; Lorenzo Galluzzi; Laura Senovilla; Frederic Schlemmer; Sandy Adjemian; Laurie Menger; Mickael Michaud; Laurence Zitvogel; Guido Kroemer
Journal:  Ann N Y Acad Sci       Date:  2010-10       Impact factor: 5.691

5.  Identification of tumor-associated proteins in oral tongue squamous cell carcinoma by proteomics.

Authors:  Qing-Yu He; Jia Chen; Hsiang-Fu Kung; Anthony Po-Wing Yuen; Jen-Fu Chiu
Journal:  Proteomics       Date:  2004-01       Impact factor: 3.984

Review 6.  Early detection of breast cancer: new biomarker tests on the horizon?

Authors:  Aparna C Jotwani; Julie R Gralow
Journal:  Mol Diagn Ther       Date:  2009-12-01       Impact factor: 4.074

7.  alphaB-crystallin is a novel predictor of resistance to neoadjuvant chemotherapy in breast cancer.

Authors:  Olga Ivanov; Feng Chen; Elizabeth L Wiley; Anjeni Keswani; Leslie K Diaz; Heidi C Memmel; Alfred Rademaker; William J Gradishar; Monica Morrow; Seema A Khan; Vincent L Cryns
Journal:  Breast Cancer Res Treat       Date:  2007-10-30       Impact factor: 4.872

8.  alphaB-crystallin: a novel p53-target gene required for p53-dependent apoptosis.

Authors:  Gou Watanabe; Shunsuke Kato; Hideyuki Nakata; Takanori Ishida; Noriaki Ohuchi; Chikashi Ishioka
Journal:  Cancer Sci       Date:  2009-08-18       Impact factor: 6.716

9.  Clinical proteomics of breast cancer.

Authors:  Y Baskın; T Yiğitbaşı
Journal:  Curr Genomics       Date:  2010-11       Impact factor: 2.236

10.  Targeting heat shock protein 27 (HspB1) interferes with bone metastasis and tumour formation in vivo.

Authors:  B Gibert; B Eckel; V Gonin; D Goldschneider; J Fombonne; B Deux; P Mehlen; A-P Arrigo; P Clézardin; C Diaz-Latoud
Journal:  Br J Cancer       Date:  2012-05-24       Impact factor: 7.640

View more
  17 in total

1.  CXCL12 chemokine expression suppresses human breast cancer growth and metastasis in vitro and in vivo.

Authors:  Zhi-Dong Lv; Bin Kong; Xiang-Ping Liu; Qian Dong; Hai-Tao Niu; Yong-Hua Wang; Fu-Nian Li; Hai-Bo Wang
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

2.  Expression of alpha B crystallin and BCL2 in patients with infiltrating ductal carcinoma.

Authors:  Mee-Seon Kim; Hyoun Wook Lee; Si-Youl Jun; Eun Hee Lee
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

3.  Overexpression of SMARCA5 correlates with cell proliferation and migration in breast cancer.

Authors:  Quanxiu Jin; Xiaoyun Mao; Bo Li; Shu Guan; Fan Yao; Feng Jin
Journal:  Tumour Biol       Date:  2014-11-07

4.  NKD1 down-regulation is associated with poor prognosis in breast invasive ductal carcinoma.

Authors:  Zhi-Dong Lv; Lin Zhang; Xiang-Ping Liu; Li-Ying Jin; Qian Dong; Fu-Nian Li; Hai-Bo Wang; Bin Kong
Journal:  Int J Clin Exp Pathol       Date:  2015-04-01

5.  CARMA3 overexpression accelerates cell proliferation and inhibits paclitaxel-induced apoptosis through NF-κB regulation in breast cancer cells.

Authors:  Tingting Zhao; Zhifeng Miao; Zhenning Wang; Yingying Xu; Jianhua Wu; Xingyu Liu; Yi You; Jiguang Li
Journal:  Tumour Biol       Date:  2013-05-25

6.  Overexpression of CRKL correlates with malignant cell proliferation in breast cancer.

Authors:  Tingting Zhao; Zhifeng Miao; Zhenning Wang; Yingying Xu; Jianhua Wu; Xingyu Liu; Yi You; Jiguang Li
Journal:  Tumour Biol       Date:  2013-05-19

Review 7.  αB-crystallin: Portrait of a malignant chaperone as a cancer therapeutic target.

Authors:  Dmitry Malin; Vladimir Petrovic; Elena Strekalova; Bhawna Sharma; Vincent L Cryns
Journal:  Pharmacol Ther       Date:  2016-01-25       Impact factor: 12.310

8.  The Discovery of Novel Biomarkers Improves Breast Cancer Intrinsic Subtype Prediction and Reconciles the Labels in the METABRIC Data Set.

Authors:  Heloisa Helena Milioli; Renato Vimieiro; Carlos Riveros; Inna Tishchenko; Regina Berretta; Pablo Moscato
Journal:  PLoS One       Date:  2015-07-01       Impact factor: 3.240

9.  Long noncoding RNA CCAT2 promotes breast tumor growth by regulating the Wnt signaling pathway.

Authors:  Yi Cai; Jing He; Dong Zhang
Journal:  Onco Targets Ther       Date:  2015-09-21       Impact factor: 4.147

10.  The functional proteomics analysis of VEGF-treated human epithelial ovarian cancer cells.

Authors:  Fan Zhang; Cui Li; Hailing Liu; Yuexiang Wang; Yile Chen; Xiaoying Wu
Journal:  Tumour Biol       Date:  2014-09-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.